Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
- PMID: 33619541
- DOI: 10.1093/ecco-jcc/jjab006
Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
Comment on
-
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial.J Crohns Colitis. 2021 Jul 5;15(7):1130-1141. doi: 10.1093/ecco-jcc/jjaa249. J Crohns Colitis. 2021. PMID: 33290538 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

